{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:59:18Z","timestamp":1760385558161,"version":"3.41.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jgar.2017.04.008","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T17:46:22Z","timestamp":1500313582000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Deficiency of quorum sensing system inhibits the resistance selection of Pseudomonas aeruginosa to ciprofloxacin and levofloxacin in vitro"],"prefix":"10.1016","volume":"10","author":[{"given":"Yating","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinju","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2017.04.008_bib0005","series-title":"Pseudomonas genomics and molecular biology","first-page":"129","article-title":"Pseudomonas aeruginosa virulence and pathogenesis issues","author":"Wagner","year":"2008"},{"issue":"Suppl 1","key":"10.1016\/j.jgar.2017.04.008_bib0010","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","article-title":"Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014","volume":"22","author":"Hu","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.jgar.2017.04.008_bib0015","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3892\/etm.2016.2983","article-title":"A three-year survey of the antimicrobial resistance of microorganisms at a Chinese hospital","volume":"11","author":"Tang","year":"2016","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.jgar.2017.04.008_bib0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/jac\/dku437","article-title":"Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa","volume":"70","author":"Rees","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.04.008_bib0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.280.5361.295","article-title":"The involvement of cell-to-cell signals in the development of a bacterial biofilm","volume":"280","author":"Davies","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jgar.2017.04.008_bib0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/jb.176.2.269-275.1994","article-title":"Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators","volume":"176","author":"Fuqua","year":"1994","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jgar.2017.04.008_bib0035","first-page":"1","article-title":"Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa","author":"Rasamiravaka","year":"2016","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.jgar.2017.04.008_bib0040","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1099\/jmm.0.45617-0","article-title":"Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa","volume":"53","author":"Schaber","year":"2004","journal-title":"J Med Microbiol"},{"year":"2016","series-title":"Performance standards for antimicrobial susceptibility testing, 26th informational supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","key":"10.1016\/j.jgar.2017.04.008_bib0045"},{"key":"10.1016\/j.jgar.2017.04.008_bib0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.45.1.267-274.2001","article-title":"Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance","volume":"45","author":"Sahm","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.04.008_bib0055","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients","volume":"37","author":"Forrest","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.04.008_bib0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.279.2.125","article-title":"Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials","volume":"279","author":"Preston","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2017.04.008_bib0065","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/AAC.31.7.1054","article-title":"Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance","volume":"31","author":"Blaser","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jgar.2017.04.008_bib0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jac\/dkl226","article-title":"Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective","volume":"58","author":"Pea","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"22","key":"10.1016\/j.jgar.2017.04.008_bib0075","first-page":"1990","article-title":"Study on antibiotic resistance of standard strains of Pseudomonas aeruginosa induced by sub-MBC of ciprofloxacin in vitro","volume":"35","author":"Yu","year":"2015","journal-title":"Chin J Hosp Pharm"},{"key":"10.1016\/j.jgar.2017.04.008_bib0080","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1371\/journal.pbio.0030176","article-title":"Inhibition of mutation and combating the evolution of antibiotic resistance","volume":"3","author":"Ryan Cirz","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jgar.2017.04.008_bib0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/.61.3.377-392.1997","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"10.1016\/j.jgar.2017.04.008_bib0090","first-page":"1386","article-title":"Prevalence and fluoroquinolone resistance of Pseudomonas aeruginosa in a hospital of South China","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"3\u20134","key":"10.1016\/j.jgar.2017.04.008_bib0095","first-page":"32","article-title":"Relation between expression of the las quorum-sensing system in clinical isolates of Pseudomonas aeruginosa and expression of efflux pump and ampC","volume":"2","author":"Pourmand","year":"2013","journal-title":"J Med Bacteriol"},{"issue":"4","key":"10.1016\/j.jgar.2017.04.008_bib0100","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.48.4.1320-1328.2004","article-title":"Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa","volume":"48","author":"Maseda","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"10.1016\/j.jgar.2017.04.008_bib0105","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/JB.180.20.5443-5447.1998","article-title":"Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa","volume":"180","author":"Evans","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jgar.2017.04.008_bib0110","article-title":"Quorum sensing system of Pseudomonas aeruginosa and its pathogenesis and resistance mechanism","volume":"06","author":"Rao","year":"2011","journal-title":"World Clin Drugs"},{"issue":"5","key":"10.1016\/j.jgar.2017.04.008_bib0115","doi-asserted-by":"crossref","DOI":"10.4103\/0971-5916.187114","article-title":"Subinhibitory concentration of ciprofloxacin targets quorum sensing system of Pseudomonas aeruginosa causing inhibition of biofilm formation & reduction of virulence","volume":"143","author":"Gupta","year":"2016","journal-title":"Indian J Med Res"},{"issue":"20","key":"10.1016\/j.jgar.2017.04.008_bib0120","first-page":"3081","article-title":"Effects of quorum sensing deficiency on P. aeruginosa biofilm formation","volume":"22","author":"Liu","year":"2006","journal-title":"Modern Med"},{"key":"10.1016\/j.jgar.2017.04.008_bib0125","first-page":"6","article-title":"Research progress on biofilm resistance of Pseudomonas aeruginosa","volume":"11","author":"Yang","year":"2009","journal-title":"Pharm Today"},{"year":"2017","series-title":"The characteristics of which the distribution of clinical isolates of Pseudomon Asaeruginosa and studies on the encoding gene of the quorum sensing system","author":"Shu-yun","key":"10.1016\/j.jgar.2017.04.008_bib0130"},{"year":"2014","series-title":"Investigation on the change of resistance of Pseudomonas aeruginosa and the effect of quorum sensing system on expression of virulence factors","author":"Xiao-xia","key":"10.1016\/j.jgar.2017.04.008_bib0135"},{"key":"10.1016\/j.jgar.2017.04.008_bib0140","first-page":"104","article-title":"Pathogenicity of clinical isolates of Pseudomonas aeruginosa with quorum sensing-deficiency","volume":"01","author":"Wang","year":"2011","journal-title":"J Huazhong Univ Sci Technol"},{"issue":"12","key":"10.1016\/j.jgar.2017.04.008_bib0145","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/j.1469-0691.2010.03177.x","article-title":"Analysis of quorum sensing-dependent virulence factor production and its relationship with antimicrobial susceptibility in Pseudomonas aeruginosa respiratory isolates","volume":"16","author":"Karatuna","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2017.04.008_bib0150","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2017.04.008_bib0155","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(03)13644-6","article-title":"Nosocomial infections in adult intensive-care units","volume":"361","author":"Vincent","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2017.04.008_bib0160","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2017.04.008_bib0165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/MMBR.60.3.539-574.1996","article-title":"Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia","volume":"60","author":"Govan","year":"1996","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.jgar.2017.04.008_bib0170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2017.04.008_bib0175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0732-8893(01)00287-5","article-title":"Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!","volume":"41","author":"Jones","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2017.04.008_bib0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjmed.2004.09.015","article-title":"Fluoroquinolone prescribing in the United States: 1995\u20132002","volume":"118","author":"Linder","year":"2005","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.jgar.2017.04.008_bib0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"Drlica","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2017.04.008_bib0190","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijantimicag.2005.10.005","article-title":"Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa","volume":"27","author":"Hansena","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"2\u20134","key":"10.1016\/j.jgar.2017.04.008_bib0195","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vetmic.2006.08.018","article-title":"Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa","volume":"4","author":"Pasquali","year":"2007","journal-title":"Vet Microbiol"},{"issue":"February (3)","key":"10.1016\/j.jgar.2017.04.008_bib0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/08927014.2017.1280732","article-title":"Furvina inhibits the 3-oxo-C12-HSL-based quorum sensing system of Pseudomonas aeruginosa and QS-dependent phenotypes","volume":"33","author":"Borges","year":"2017","journal-title":"Biofouling"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517300899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517300899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T03:42:47Z","timestamp":1750650167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716517300899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"alternative-id":["S2213716517300899"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2017.04.008","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of quorum sensing system inhibits the resistance selection of Pseudomonas aeruginosa to ciprofloxacin and levofloxacin in vitro","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2017.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}